Following The Money: Institution’s Growing Stake In FibroGen Inc (NASDAQ: FGEN)
FibroGen Inc (FGEN) concluded trading on Wednesday at a closing price of $0.33, with 3.92 million shares of worth about $1.29 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -72.08% during that period and on November 13, 2024 the price saw a loss […]
FibroGen Inc (FGEN): Not A Time To Panic Nor Freeze
FibroGen Inc (FGEN) concluded trading on Thursday at a closing price of $0.40, with 2.69 million shares of worth about $1.08 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -66.24% during that period and on October 17, 2024 the price saw a gain […]
FibroGen Inc (NASDAQ: FGEN): Analyst View Points To Future Growth
FibroGen Inc (FGEN) concluded trading on Thursday at a closing price of $2.38, with 4.05 million shares of worth about $9.63 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 73.72% during that period and on Thursday the price saw a gain of about […]
Why Should You Put FibroGen Inc (NASDAQ: FGEN) On Your Portfolio?
Insiders at the company have transacted a total of 88 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 25 of these insider trades were purchases, accounting for 758,136 shares. Insider sales of the common stock occurred on 63 occasions, with total insider shares sold totaling […]
FibroGen Inc (NASDAQ: FGEN) Seen Running Too Hot, Let’s Look At This More Closely
PRIMECAP Management Co. recently announced the acquisition of new stake in FibroGen Inc (NASDAQ:FGEN). The institutional investor has increased its shareholding in the Healthcare company by 7.66% to 14.72 million shares with purchase of 1.05 million shares. This fresh investment now brings its stake to 14.97% valued currently at $13.05 million. In addition, Armistice Capital […]
